Literature DB >> 17533975

[Positron emission tomography with FDG and newly developed tracers for the assessment of brain metabolism and synaptic function in neurological disorders].

Toshimitsu Momose1.   

Abstract

Positron emission tomography has enabled us to measure various fundamental parameters of human brain physiology and chemistry, such as cerebral blood flow, metabolism and synaptic functions. Blood flow and oxygen metabolism is important for the understanding of cerebro-vascular disease. Glucose metabolism is tightly coupled with brain function and FDG-PET is useful for the determination of epileptic foci and for the evaluation of tumor malignancy. Imaging analysis of functional neuroanatomy of these parameters is very promising for the early diagnosis of dementia, such as Alzheimer's disease. Measurement of pre- and post-synaptic function is applicable to the differential diagnosis of parkinsonism. In early stage of Parkinson's disease, only presynaptic dopaminergic function is impaired, while in multiple system atrophy with striato-nigral degeneration type, both pre-and post dopaminergic function is reduced. Development of new radiotracers is expected for detection of early specific pathological changes and more previous changes underlying the deterioration of neurochemistry, such as genetic abnormalities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533975

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  2 in total

Review 1.  Recent advances in PET imaging for evaluation of Parkinson's disease.

Authors:  Chrissa Sioka; Andreas Fotopoulos; Athanassios P Kyritsis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-27       Impact factor: 9.236

2.  Gamma knife treatment for refractory epilepsy in seizure focus localized by positron emission tomography/CT.

Authors:  Xia Bai; Xuemei Wang; Hongwei Wang; Shigang Zhao; Xiaodong Han; Linjun Hao; Xiangcheng Wang
Journal:  Neural Regen Res       Date:  2012-12-25       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.